177 related articles for article (PubMed ID: 33395363)
1. Epigenetic mechanisms influencing COVID-19.
Sen R; Garbati M; Bryant K; Lu Y
Genome; 2021 Apr; 64(4):372-385. PubMed ID: 33395363
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus
Beacon TH; Delcuve GP; Davie JR
Genome; 2021 Apr; 64(4):386-399. PubMed ID: 33086021
[TBL] [Abstract][Full Text] [Related]
3. Modulation of host epigenome by coronavirus infections and developing treatment modalities for COVID-19 beyond genetics.
Rabaan AA; Al Mutair A; Alhumaid S; Al Alawi Z; Al Mohaini M; Alsalman AJ; Fawzy M; Al-Tawfiq JA; Almahmoud S; Alfouzan W; Bilal M; Dhawan M; Mohapatra RK; Tiwari R; Khan Z; Mitra S; Emran TB; Dhama K
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(19):5947-5964. PubMed ID: 34661254
[TBL] [Abstract][Full Text] [Related]
4. Involvement of epigenetics in affecting host immunity during SARS-CoV-2 infection.
Behura A; Naik L; Patel S; Das M; Kumar A; Mishra A; Nayak DK; Manna D; Mishra A; Dhiman R
Biochim Biophys Acta Mol Basis Dis; 2023 Mar; 1869(3):166634. PubMed ID: 36577469
[TBL] [Abstract][Full Text] [Related]
5. Coronavirus disease 2019 and asthma, allergic rhinitis: molecular mechanisms and host-environmental interactions.
Wakabayashi M; Pawankar R; Narazaki H; Ueda T; Itabashi T
Curr Opin Allergy Clin Immunol; 2021 Feb; 21(1):1-7. PubMed ID: 33186186
[TBL] [Abstract][Full Text] [Related]
6. Genetic and epigenetic control of ACE2 expression and its possible role in COVID-19.
Lima RS; Rocha LPC; Moreira PR
Cell Biochem Funct; 2021 Aug; 39(6):713-726. PubMed ID: 34075603
[TBL] [Abstract][Full Text] [Related]
7. An immune epigenetic insight to COVID-19 infection.
Jit BP; Qazi S; Arya R; Srivastava A; Gupta N; Sharma A
Epigenomics; 2021 Mar; 13(6):465-480. PubMed ID: 33685230
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic mechanisms regulating COVID-19 infection.
Chlamydas S; Papavassiliou AG; Piperi C
Epigenetics; 2021 Mar; 16(3):263-270. PubMed ID: 32686577
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics.
Beacon TH; Su RC; Lakowski TM; Delcuve GP; Davie JR
IUBMB Life; 2020 Nov; 72(11):2331-2354. PubMed ID: 32936531
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic Evolution of ACE2 and IL-6 Genes: Non-Canonical Interferon-Stimulated Genes Correlate to COVID-19 Susceptibility in Vertebrates.
Sang ER; Tian Y; Miller LC; Sang Y
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33503821
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic alterations and genetic variations of angiotensin-converting enzyme 2 (ACE2) as a functional receptor for SARS-CoV-2: potential clinical implications.
Kianmehr A; Faraoni I; Kucuk O; Mahrooz A
Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1587-1598. PubMed ID: 33939044
[TBL] [Abstract][Full Text] [Related]
12. Assessing COVID-19 susceptibility through analysis of the genetic and epigenetic diversity of ACE2-mediated SARS-CoV-2 entry.
Ragia G; Manolopoulos VG
Pharmacogenomics; 2020 Dec; 21(18):1311-1329. PubMed ID: 33243086
[TBL] [Abstract][Full Text] [Related]
13. Genomic, epigenomic, and immune subtype analysis of CTSL/B and SARS-CoV-2 receptor ACE2 in pan-cancer.
Li H; Xie L; Chen L; Zhang L; Han Y; Yan Z; Guo X
Aging (Albany NY); 2020 Nov; 12(22):22370-22389. PubMed ID: 33231569
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks.
Kgatle MM; Lawal IO; Mashabela G; Boshomane TMG; Koatale PC; Mahasha PW; Ndlovu H; Vorster M; Rodrigues HG; Zeevaart JR; Gordon S; Moura-Alves P; Sathekge MM
Front Immunol; 2021; 12():752380. PubMed ID: 34691068
[TBL] [Abstract][Full Text] [Related]
15. The unfavorable clinical outcome of COVID-19 in smokers is mediated by H3K4me3, H3K9me3 and H3K27me3 histone marks.
Shirvaliloo M
Epigenomics; 2022 Feb; 14(3):153-162. PubMed ID: 35021853
[TBL] [Abstract][Full Text] [Related]
16. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
Huang SW; Miller SO; Yen CH; Wang SF
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic mechanisms and host factors impact ACE2 gene expression: Implications in COVID-19 susceptibility.
Daniel G; Paola AR; Nancy G; Fernando SO; Beatriz A; Zulema R; Julieth A; Claudia C; Adriana R
Infect Genet Evol; 2022 Oct; 104():105357. PubMed ID: 36038007
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.
Lite C; Ahmed SSSJ; Juliet M; Freddy AJ
Pathog Dis; 2021 Feb; 79(2):. PubMed ID: 33469663
[TBL] [Abstract][Full Text] [Related]
19. Identifying the Zoonotic Origin of SARS-CoV-2 by Modeling the Binding Affinity between the Spike Receptor-Binding Domain and Host ACE2.
Huang X; Zhang C; Pearce R; Omenn GS; Zhang Y
J Proteome Res; 2020 Dec; 19(12):4844-4856. PubMed ID: 33175551
[TBL] [Abstract][Full Text] [Related]
20. Population-Specific
Hashizume M; Gonzalez G; Ono C; Takashima A; Iwasaki M
Viruses; 2021 Jan; 13(1):. PubMed ID: 33418950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
